Search results

Conducting research and clinical studies outside of academic institutions requires perseverance and time. It is often necessary to recruit, and train dedicated teams but also to set up infrastructures. Dive into the heart of the clinical trial aimed at evaluating the optimal interval between two doses of cholera vaccine coordinated by Epicentre in Guinea and sponsored by MSF, to discover the multiple steps, from its genesis to the acquisition of results.

In early October 2022, the third and final round of the joint MSF and South Sudanese Ministry of Health hepatitis E campaign began in Bentiu IDP camp, Unity State, South Sudan. This vaccination raises hopes in the fight against this particularly deadly disease for pregnant women. In parallel, Epicentre is conducting a study to evaluate the effectiveness in real conditions of this vaccine which has been shown to be highly effective in preventing the disease in clinical trials, which the World Health Organization (WHO) has recommended for use in outbreak responses since 2015.